Precision-built for sterility, engineered for scale — a dedicated sterile manufacturing facility delivering injectables, dry powder inhalers and ophthalmic formulations under the most demanding standards of sterility, safety and global regulatory compliance.
Located in the SIDCUL industrial belt of Haridwar, Uttarakhand, the facility is dedicated to the manufacture of sterile pharmaceutical formulations, built around cutting-edge sterile processing technology.
Every formulation is produced under strict regulatory guidelines, with a singular focus on sterility assurance, precision and compliance — meeting the rigorous requirements that patient safety and efficacy demand, for markets across the world.
Sterile Dosage Categories
Therapy Areas Served
Global Regulatory Approvals
Sterile Manufacturing Focus
From high-volume parenterals to dedicated inhalation and ophthalmic lines, our sterile capability is built to deliver consistency, purity and precision at every scale.
A comprehensive parenteral portfolio across small and large volumes, engineered for aseptic precision.
A dedicated, segregated production block purpose-built for cephalosporin dry powder inhaler formulations.
A dedicated, segregated production block purpose-built for penicillin dry powder inhaler formulations, fully independent from beta-lactam-sensitive lines.
Fine-tuned sterile formulations for delicate application sites, produced to exacting purity standards.
Our sterile dosage form capabilities support therapy areas where purity, dosing accuracy and speed of action matter most.
Dedicated cephalosporin and penicillin manufacturing for targeted infection therapy.
Large and small volume parenterals for hospital and critical-care settings.
Dry powder inhalers formulated for fast, reliable respiratory relief.
Sterile eye drop formulations built for precision and comfort.
Nasal formulations designed for targeted, fast-acting relief.
Broad injectable capability supporting diverse treatment protocols.
Sterile manufacturing calls for a level of process discipline few facilities can match. Dedicated, segregated production blocks for cephalosporin and penicillin formulations eliminate cross-contamination risk, while aseptic fill-finish technology across ampoules, vials and pre-filled syringes ensures every unit meets the same exacting standard, batch after batch.
Segregated blocks keep cephalosporin and penicillin production fully independent.
Sterile processing technology engineered for consistency across every format.
Process controls built to satisfy the world's most demanding regulators.
Our sterility and quality standards are validated not just at home, but by regulatory authorities across the globe — a reflection of manufacturing discipline built for international markets.
Certified to European Union Good Manufacturing Practice standards.
Approved by the Brazilian Health Regulatory Agency (ANVISA), Brazil.
Beyond regulatory approvals, our management systems are independently certified across quality, environment, safety and energy — the operational foundation behind every sterile batch.
Quality Management System
Environmental Management
Occupational Health & Safety
Energy Management
Approved by the Food Safety and Drug Administration, Uttarakhand.
Cutting-edge sterile processing technology, disciplined segregation protocols and a strong quality culture come together to deliver sterile products with consistency, safety and speed — for patients across the globe.
Purpose-equipped production lines built specifically for aseptic and sterile formulation manufacturing.
Strict adherence to regulatory guidelines ensures every formulation meets rigorous safety and efficacy requirements.
Production capability recognized by regulators across continents, built to serve diverse healthcare systems.
Plant-III manufactures Sterile Injectables (Ampoules, Vials, Three-Piece Vials, LVP, SVP, Pre-Filled Syringes), Dry Powder Inhalers across dedicated Cephalosporin and Penicillin blocks, and Nasal & Eye Care formulations (Nasal Drops, Eye Drops).
Plant-III is located in the SIDCUL industrial belt of Haridwar, Uttarakhand, India.
Yes. Cephalosporin (Unit II) and Penicillin (Unit III) dry powder inhaler formulations are manufactured in dedicated, segregated production blocks to eliminate cross-contamination risk.
Plant-III is EU-GMP certified and ANVISA approved, with further recognition from regulators including the Bulgarian Drug Agency, NAFDAC Nigeria, the Philippines FDA, and the National Drug Authority of Uganda, among others.
Yes. Plant-III supports third-party and contract manufacturing programs across its Injectables, DPI and Nasal & Eye Care lines. Reach out via the form below to discuss your project requirements.
Sterile preparations is just one expression of our manufacturing capability. Across the wider organization, our formulation expertise extends into many more dosage forms and therapeutic categories — each engineered with the same commitment to quality, precision and reliability.
Partner with Akums to elevate your pharmaceutical, nutraceutical, and cosmetic supply chain. As India's leading CDMO, we offer end-to-end solutions, including R&D, formulation development, and large-scale manufacturing. Our state-of-the-art facilities comply with stringent global standards, ensuring product safety, efficacy, and quality. With a strong focus on innovation, we deliver tailored solutions to meet your unique business needs. Whether you're launching a new product or enhancing your current supply chain, Akums provides reliable expertise, seamless scalability, and unwavering commitment to excellence. Join hands with Akums to strengthen your brand and achieve sustained growth in competitive markets.